Abstract
Molecular classification of diffuse large B-cell lymphoma (DLBCL) is a critical biologic, prognostic, and predictive distinction. Since the discovery of two molecular types of DLBCL in otherwise morphologically indistinguishable cases, numerous methodologies for making this distinction have been published. A method and technical platform may now be reaching consensus.
Original language | English (US) |
---|---|
Pages (from-to) | 2204-2206 |
Number of pages | 3 |
Journal | Clinical Cancer Research |
Volume | 21 |
Issue number | 10 |
DOIs | |
State | Published - May 15 2015 |
ASJC Scopus subject areas
- Oncology
- Cancer Research